Post-earnings recap
Reported
Wed, May 6, 2026
EPS actual
$0.82
EPS est.
$1.11
EPS surprise
-25.93%
1-day move
+0.10%
Penumbra, Inc. reported earnings that fell short of expectations, particularly in EPS, which may raise concerns among investors. Despite the earnings miss, the stock saw a slight increase of 0.1%, indicating that investors may be taking a wait-and-see approach. The lack of revenue data and management commentary leaves uncertainty about the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.82 | $1.06 | -25.93% |
| Revenue | — | $372M | — |
No transcript is on record, and the analysis is based on numerical results only.
Penumbra, Inc. is a healthcare company that develops innovative medical devices for treating vascular and neurovascular conditions. With a market cap of $13 billion, it plays a significant role in the health care equipment sector, focusing on improving patient outcomes through advanced technology.
Last quarter
In Q4 2025, Penumbra reported an EPS of $1.18, exceeding expectations by 5.36%. However, the stock experienced a slight decline of 0.27% the following day.
EPS beat streak
0Q
EPS beat rate
75%
Avg EPS surprise
+3.00%
Avg 1-day reaction
-0.42%
Analysts expect Penumbra to report solid earnings this quarter, with a consensus EPS of $1.06 and revenue of $372 million. The company has a strong track record of beating EPS estimates, which could influence investor sentiment.
Bull case
If Penumbra exceeds EPS and revenue expectations, it could signal strong demand for its products and lead to increased investor confidence, potentially driving the stock higher.
Bear case
Conversely, if the company fails to meet expectations, it may raise concerns about its growth trajectory and market competition, leading to a negative reaction in the stock price.
Key metrics to watch
Earnings Per Share (EPS)
$1.06EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Revenue
$372MRevenue growth is crucial for assessing the company's ability to expand its market presence and invest in future innovations.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $1.06?
A beat on EPS could reinforce investor confidence in Penumbra's growth and operational efficiency.
Q2
What is the revenue outlook compared to the consensus of $372 million?
Revenue performance is critical for understanding the company's market demand and future growth potential.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
While the consensus expects steady growth, there may be underappreciated risks related to market competition and product adoption rates that could lead to a disappointing quarter.
Supporting evidence
The stock has historically reacted negatively even after earnings beats, suggesting that expectations may be overly optimistic.
Options pricing indicates a higher expected move than historical averages, hinting at potential volatility that the market may not fully anticipate.
Key risk
If revenue growth shows signs of slowing or if competitive pressures are highlighted in the earnings call, it could significantly challenge the current consensus.
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as it will reflect the company's ability to sustain growth amid competitive pressures.
Bull confirmed if
An EPS of $1.10 or higher, along with revenue exceeding $375 million, would confirm the bull case.
Bear confirmed if
An EPS below $1.00 or revenue falling short of $365 million would support the bear case.
What the market is pricing for the move.
Implied Move
±2.09%
Historical Avg
±1.0%
The options market is pricing in a modest move of about 2.09%, suggesting that investors are anticipating some volatility around the earnings report.
Options are pricing ±2.1% while PEN has averaged ±1.0% over the last 8 prints — setup is pricing rich.
ATM IV
0.2%
30d HV
10.1%
Smart-money positioning from the most recent 13F filings.
Institutional
88.31%
of float
Insider
2.90%
of float
Holders
589
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
4,297,555 sh · $1.4B
10.91%
-0.8%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Penumbra beats expectations, history suggests a potential average one-day move of +2.12%, confirming strong demand for its products.
In line / cautious
Should the results come in line with expectations, the stock may see muted movement as investors await further guidance.
Miss
A miss on earnings could lead to a decline, with historical patterns indicating an average one-day move of -0.77%.
The lines on the call that would change the story.
HBK Investments L P
1,838,508 sh · $581.6M
4.67%
12.5%
Vanguard Capital Management LLC
1,709,877 sh · $540.9M
4.34%
0.9%
Vanguard Portfolio Management LLC
1,667,276 sh · $527.4M
4.23%
0.8%
State Street Corporation
1,243,258 sh · $393.3M
3.16%
4.8%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.